KMID : 1148920080420000017
|
|
Nuclear Medicine and Molecular Imaging 2008 Volume.42 No. 0 p.17 ~ p.28
|
|
Clinical Application of 18F-FDG PET in Non-Small Cell Lung Cancer
|
|
Choi Joon-Young
|
|
Abstract
|
|
|
This review focuses on the clinical use of 18F-FDG PET to evaluate solitary pulmonary nodule (SPN) and non-small cell lung cancer (NSCLC). When SPN or mass without calcification is found on chest X-ray or CT, 18F-FDG PET is an effective modality to differentiate benign from malignant lesions. For initial staging of NSCLC, 18F-FDG PET is useful, and proved to be cost-effective in several countries. 18F-FDG PET is useful for detecting recurrence, restaging and evaluating residual tumor after curative therapy in NSCLC. For therapy response assessment, 18F-FDG PET may be effective after chemotherapy or radiation therapy. 18F-FDG PET is useful to predict pathological response after neoadjuvant therapy in NSCLC. For radiation therapy planning, 18F-FDG PET may be helpful, but requires further investigations. PET/CT is better for evaluating NSCLC than conventional PET. (Nucl Med Mol Imaging 2008;42(suppl 1):17-28)
|
|
KEYWORD
|
|
solitary pulmonary nodule, non-small cell lung cancer, 18F-FDG, PET
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|